Table 2.

Prevalence of antigen markers for both total sample and AML excluding APL

Antigen markers	Total AML sample (n=209)		AML excluding APL (n=183)
	n	Percent	n	Percent
Single markers
CD2+	38	18.18	34	18.58
CD4+	131	62.68	121	66.12
CD5+	6	2.87	6	3.28
CD7+	58	27.75	58	31.69
CD8+	0	0.00	0	0.00
CD10+	28	13.40	28	15.30
C11B+	86	41.15	83	45.36
C11C+	89	42.58	89	48.63
CD13+	190	90.91	165	90.16
CD14+	34	16.27	34	18.58
CD15+	139	66.51	123	67.21
CD16+	3	1.44	3	1.64
CD19+	17	8.13	16	8.74
CD20+	0	0.00	0	0.00
CD22+	5	2.39	5	2.73
CD23+	7	3.35	7	3.83
CD25+	22	10.53	22	12.02
CD33+	181	86.60	156	85.25
CD34+	149	71.29	140	76.50
CD36+	71	33.97	68	37.16
CD38+	192	91.87	170	92.90
CD56+	41	19.62	39	21.31
CD117+	167	79.90	146	79.78
HLA-DR+	157	79.29	155	90.12
Combination markers
CD34+/HLA-DR+	124	59.33	123	67.21
CD13+/CD33+/CD117+	136	65.07	116	63.39
CD34+/HLA-DR+/CD7+	46	22.01	46	25.14
CD34+/HLA-DR+/CD56+	20	9.57	20	10.93
CD34+/CD7+	51	24.40	51	27.87
CD34+/CD56+	26	12.44	25	13.66
CD11B+/CD11C+/CD36+/CD14+ (must express 3 of 4)	50	23.92	50	27.32
	(n=199)		(n=173)
CD56+ with t(15;17)	2	1.01	0	0.00
CD56+ with t(8;21)	2	1.01	2	1.16
CD56+ with inv(16)	2	1.01	2	1.16